Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications

Miroslava Marinova (University of East London), Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications (2023): The legal treatment of excessive pricing in the pharmaceutical sector has been a...
Source: HealthLawProf Blog - Category: Medical Law Authors: Source Type: blogs